The role of general practitioner in the study of adverse drug reactions epidemiology in ambulatory care setting

Main Article Content

Jose Luis Turabian*

Abstract



Adverse drug reactions (ADRs) cause considerable mortality and morbidity. Its importance becomes greater in relation to the current increase in the use of drugs and multimorbidity. Premarketing studies do not allow a complete knowledge of the safety of a medicine. Many ADRs occurring in the outpatient setting, but there is a significant lack of information regarding the epidemiology of ADRs in this level of health care. Thus, guidance on how to direct attention to effective targets for improvement of medication safety in ambulatory care settings is missing. In this scenario, the general practitioner (GP) is in a rare, special position in the health system, which allows him to combine the clinical tasks of diagnosis and treatment on individuals with epidemiological and public health tasks on communities, including a important role in the study of ADRs’s epidemiology. Among the methods aimed at identifying and quantifying the ADRs, in the GP consultation, we have: 1) Data derived from pure clinical observation; 2) Voluntary spontaneous notification systems; 3) Effective local initiatives for improving the collection of reports on ADRs; 4) Careful epidemiological studies, which may include descriptive studies (cross-sectional), retrospective (case-control), prospective (cohort), clinical trials, and single-case studies, seasonal variations, longitudinal studies, etc.; 5) Patient reporting of ADRs; 6) The use of algorithms for the diagnostic of ADRs; 7) Intensive telephone surveillance; 8) Collaborative work with Pharmacists working in the community; 9) From the position of the GP (where the entire medical care process begins and ends) the incidence rate of ADRs caused by hospital prescribed drugs can also be observed and collected from discharge of the hospital admissions; And 10) Genetics and electronic health records can go together to identify heritable traits to predisposition to ADRs.


“The scientific purist, who will wait for medical statistics until they are nosologically exact, is no wiser than Horace’s rustic waiting for the river to flow away.” Major Greenwood, 1948.



Downloads

Download data is not yet available.

Article Details

Turabian, J. L. (2019). The role of general practitioner in the study of adverse drug reactions epidemiology in ambulatory care setting. Archives of Community Medicine and Public Health, 5(1), 003–007. https://doi.org/10.17352/2455-5479.000045
Research Articles

Copyright (c) 2019 Turabian JL.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Patton K, Borshoff DC (2018) Adverse drug reactions. Anaesthesia. 73: 76-84. Link: https://goo.gl/kqqrfU

Coleman JJ, Pontefract SK (2016) Adverse drug reactions. Clin Med (Lond). 16: 481-485. Link: https://goo.gl/X8M7zm

Rabinovitz H, Berkowitch M, Golik A, Shani S (2001) Adverse drug reactions definitions and terminology. Article in Hebrew Harefuah 140: 1181-1186, 1228. Link: https://goo.gl/pVDfoz

Pourpak Z, Fazlollahi MR, Fattahi F (2008) Understanding adverse drug reactions and drug allergies: principles, diagnosis and treatment aspects. Recent Pat Inflamm Allergy Drug Discov 2: 24-46. Link: https://goo.gl/hSVhrR

Gummadi T, Harave VS, Aiyar LN, RajaLekshmi SG, Kunnavil R (2017) Adverse drug reaction monitoring in a tertiary care psychiatry setting: A comparative study between inpatients and outpatients. Indian J Psychol Med 39: 306-311. Link: https://goo.gl/C632ph

Bouvy JC, De Bruin ML, Koopmanschap MA (2015) Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies. Drug Saf 38: 437-453. Link: https://goo.gl/nMUQhP

Taché SV, Sönnichsen A, Aschcroft DM (2011) Prevalence of adverse events in ambulatory care: a systematic review. Ann Pharmacother 45: 977-989. Link: https://goo.gl/7DMZKh

Bourgeois FT, Shannon MW,Valim C, Mandl KD (2010) Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 19: 901-910. Link: https://goo.gl/V5ttn3

Davies EA, O’Mahony MS (2015) Adverse drug reactions in special populations – the elderly. Br J Clin Pharmacol 80: 796-807. Link: https://goo.gl/rBmXzt

Loke YK (2012) Adverse drug reactions. Br J Clin Pharmacol 73: 908-911. Link: https://goo.gl/A9mb5C

Gholami K, Ziaie S, Shalviri G (2008) Adverse drug reactions induced by cardiovascular drugs in outpatients. Pharm Pract (Granada). 6: 51-55. Link: https://goo.gl/vBkHxL

Wooten JM (2010) Adverse drug reactions: Part I. South Med J 103: 1025-1028. Link: https://goo.gl/SZYKqc

Turabian JL (2018) The "power-law" phenomenon in health problems among patients in family medicine: 20% of patients present 50% of health problems. SF J Pub Health 1: 3. Link: https://goo.gl/KRScmK

Agosti V, Quitkin FM, Stewart JW, McGrath PJ (2002) Somatization as a predictor of medication discontinuation due to adverse events. Int Clin Psychopharmacol 17: 311-314. Link: https://goo.gl/cN9X4o

Gutiérrez-Islas, Báez-Montiel BB, Turabian JL, Bolaños-Maldonadoa M, Herrera-Ontañón JR, et al. (2012) [Patients with adverse drug reactions have a higher prevalence of emotional disorders]. [Article in Spanish]. Aten Primaria 44: 720-726. Link: https://goo.gl/VGM1tP

Turabián Fernández JL, Pérez Franco B (2010) The concept of treatment in familiy medicine: A contextualised and contextual map of a city hardly seen. Aten Primaria 42: 253-254. Link: https://goo.gl/gxHYcK

Turabian JL (2018) Doctor-Patient Relationship in Pharmacological Treatment: Discontinuation and Adherence. COJ Rev & Res 1: COJRR.000521. Link: https://goo.gl/YCW75L

Turabian JL (2017) Prevalence of Chronic Diseases: in Defence of Epidemiological Craftsmanship in Family Medicine. CP Epidemiology. 1: 005. Link: https://goo.gl/C2qEQK

Turabian JL (1995) Notebooks of Family and Community Medicine. An introduction to the principles of Family Medicine. Madrid: Díaz de Santos. Link: https://goo.gl/HiKWME

Turabian JL (2018) The Varieties of the Epidemiological Experiences and the Contribution of the General Physician. J Community Prev Med 1: 1-5. Link: https://goo.gl/nbznuH

Mackenzie J ( 2013) A Defence of the Thesis that “The opportunities of the general practitioner are essential for the investigation of disease and the progress of medicine”. Int J Epidemiol 41: 1507-1518. Link: https://goo.gl/52Twdz

Turabian JL (2018) Community medicine from the point of view of the general practitioner: “Never plump your foot straight into your shoe in the morning". International Journal of Advanced Community Medicine 1: 44-50. Link: https://goo.gl/yviHzp

Fry J (1992) Common Diseases: Their Nature Incidence and Care. Lancaster,England: MTP Press Limited.

Sahu RK, Yadav R, Prasad P, Roy A, Chandrakar S (2014) Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance. Springerplus 3: 695. Link: https://goo.gl/q92irF

Naidu RP (2013) Causality assessment: A brief insight into practices in pharmaceutical industry. Perspect Clin Res 4: 233-236. Link: https://goo.gl/oZgDDG

Srba J, Descikova V, Vlcek J (2012) Adverse drug reactions: analysis of spontaneous reporting system in Europe in 2007-2009. Eur J Clin Pharmacol 68: 1057-1063. Link: https://goo.gl/H7G8mq

Anonymous (2012) Towards better reporting of adverse drug reactions. Prescrire Int 21: 128-129. Link: https://goo.gl/YJ1Swy

Alomar MJ (2014) Factors affecting the development of adverse drug reactions (Review article). Saudi Pharmaceutical Journal 22: 83-94. Link: https://goo.gl/FMckdd

Kampichit S, Pratipanawatr T, Jarernsiripornkul N (2018) Confidence and accuracy in identification of adverse drug reactions reported by outpatients. Int J Clin Pharm 40: 1559-1567. Link: https://goo.gl/uE1gCG

Walter SR, Gallego B (2018) Detecting Adverse Drug Events: Accuracy and Generalizability. Ther Innov Regul Sci. Link: https://goo.gl/FALUum

Doherty MJ (2009) Algorithms for assessing the probability of an Adverse Drug Reaction. Respir Med CME 2: 63-67. Link: https://goo.gl/WzDqV2

Chakradhar S (2019) Calculated risk. Nat Med 25: 6–8. Link: https://goo.gl/Z93wMj

Kaushal R, Goldmann DA, Keohane CA, Christino M, Honour M, et al. (2007) Adverse drug events in pediatric outpatients. Ambul Pediatr 7: 383-389. Link: https://goo.gl/6s8HxA

Brahma DK, Wahlang JB, Marak MD, Ch Sangma M (2013) Adverse drug reactions in the elderly. J Pharmacol Pharmacother 4: 91-94. Link: https://goo.gl/gTMYLU

Crispo JAG, Thibault DP, Willis AW (2018) Adverse Drug Events as a Reason for Adult Hospitalization: A Nationwide Readmission Study. Ann Pharmacother. Link: https://goo.gl/kTp7Yx

Turabian (2018) Strategies to Increase Opportunities to Identify and Communicate Adverse Drug Reactions and Drug Related Problems in General Medicine. J Family Med Community Health 5: 1165. Link: https://goo.gl/DvuA8x

Greenwood M (1948) Medical statistics from Graunt to Farr. Cambridge, Cambridge University Press. Link: https://goo.gl/hrJYH4

Wooten JM (2010) Adverse drug reactions: part II. South Med J 103: 1138-1145. Link: https://goo.gl/5zBYAt

Mangoni AA (2012) Predicting and detecting adverse drug reactions in old age: challenges and opportunities. Expert Opin Drug Metab Toxicol 8: 527-530. Link: https://goo.gl/hNHhxh

Most read articles by the same author(s)